Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery
Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery: The Role of OCT- Angiography
1 other identifier
observational
14
1 country
1
Brief Summary
This study evaluates the retinal vascular features using optical coherence tomography angiography in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedFirst Submitted
Initial submission to the registry
June 8, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedJune 16, 2020
June 1, 2020
2 months
June 8, 2020
June 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Study of vessel density of the optic disc in patients underwent Endoscopic Endonasal Pituitary Surgery for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.
To evaluate the role of optical coherence tomography angiography in predicting the recovery of the vessel density of the optic disc after surgery, using optical coherence tomography angiography (OCTA). The parameter analyzed by OCTA was the vessel density of the optic disc (percent)
48 hours
Interventions
Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter.
Eligibility Criteria
The participans were older than 45 years with pituitary adenoma. They did not present other ophthalmological and neurological diseases.
You may qualify if:
- age older than 45 years
- diagnosis of pituitary adenoma
- treatment-naïve with Endoscopic Endonasal Pituitary Surgery
- absence of other neurological diseases
- absence of vitreoretinal and vascular retinal diseases
You may not qualify if:
- age younger than 45 years
- No diagnosis of pituitary adenoma
- previous treatments with Endoscopic Endonasal Pituitary Surgery
- presence of neurological diseases
- presence of vitreoretinal and vascular retinal diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Naples "Federico II"
Naples, 80100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gilda Cennamo
Federico II University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 8, 2020
First Posted
June 11, 2020
Study Start
January 1, 2019
Primary Completion
March 1, 2019
Study Completion
March 31, 2019
Last Updated
June 16, 2020
Record last verified: 2020-06